Skip to content
Screener

Precigen PGEN Price / book

Price / book at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.3×-0.2×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.1×+0.2×
Gilead Sciences logo
Gilead SciencesGILD
13.3×+6.5×
Allogene Therapeutics logo
Allogene TherapeuticsALLO
2.1×+1.3×
Regenxbio logo
RegenxbioRGNX
8.6×+6.6×
Opko Health logo
Opko HealthOPK
1×+0.2×

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.59B+404%
Enterprise value$2.68B+431%
P/S97.5×—

Profitability

See full
Gross margin83.6%—
Operating margin-2,890.9%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

market cap/total stockholders equity=67.7×

Based on the most recent quarter.

The source filing: Precigen’s 10-Q, filed May 13, 2026. Open the filing →

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017

FAQ

What is Precigen's price / book?
Precigen (PGEN) reported price / book of 67.7× in Q1 2026.
What is the long-term trend for Precigen's price / book?
Over 5 years (2020 to 2025), Precigen's price / book has grown at a 19.2% compound annual growth rate (CAGR), from 29.4× to 70.7×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Precigen's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude